Trials / Completed
CompletedNCT01107067
Testosterone Replacement Therapy Decreases Plasma Paraoxonase 1 Enzyme Activity In Male Patients With Hypogonadism
Phase IV Study to Investigate the Effect of Testosterone Treatment on Paraoxonase Level in Male Patients With Hypogonadotrophic Hypogonadism
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Gulhane School of Medicine · Academic / Other
- Sex
- Male
- Age
- 20 Years – 25 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is investigating the effect of testosterone treatment on paraoxonase level in male patients with hypogonadotrophic hypogonadism
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sustanon | 250 mg/21 days |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2010-04-20
- Last updated
- 2010-04-20
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01107067. Inclusion in this directory is not an endorsement.